Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jamal Rahaman

Showing results (21-30 of 26) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 26 results.
Radiographics : a Review Publication of the Radiological Society of North America, Inc|March 19, 2011
Role of FDG PET/CT in staging of recurrent ovarian cancerHongju Son, Shahid M Khan, Jamal Rahaman, et al.
International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists|October 3, 2017
Sentinel Lymph Node Ultra-staging as a Supplement for Endometrial Cancer Intraoperative Frozen Section DeficienciesMorgan Blakely, Yuxin Liu, Jamal Rahaman, et al.
American Journal of Obstetrics and Gynecology|August 1, 2008
Patient clinical factors influencing use of hysterectomy in New York, 2001-2005Herbert Gretz, William H Bradley, Konstantin Zakashansky, et al.
Gynecologic Oncology|July 5, 2014
Interferon regulatory factor 1 is an independent predictor of platinum resistance and survival in high-grade serous ovarian carcinomaSamantha Cohen, Rebecca Mosig, Erin Moshier, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|December 21, 2013
The role of liver resection at the time of secondary cytoreduction in patients with recurrent ovarian cancerValentin Kolev, Elena B Pereira, Myron Schwartz, et al.
Nature Communications|January 8, 2014
microRNA-181a has a critical role in ovarian cancer progression through the regulation of the epithelial-mesenchymal transitionAditya Parikh, Christine Lee, Peronne Joseph, et al.
Pageof 3

Showing results (21-30 of 26) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 26 results.
Radiographics : a Review Publication of the Radiological Society of North America, Inc|March 19, 2011
Role of FDG PET/CT in staging of recurrent ovarian cancerHongju Son, Shahid M Khan, Jamal Rahaman, et al.
International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists|October 3, 2017
Sentinel Lymph Node Ultra-staging as a Supplement for Endometrial Cancer Intraoperative Frozen Section DeficienciesMorgan Blakely, Yuxin Liu, Jamal Rahaman, et al.
American Journal of Obstetrics and Gynecology|August 1, 2008
Patient clinical factors influencing use of hysterectomy in New York, 2001-2005Herbert Gretz, William H Bradley, Konstantin Zakashansky, et al.
Gynecologic Oncology|July 5, 2014
Interferon regulatory factor 1 is an independent predictor of platinum resistance and survival in high-grade serous ovarian carcinomaSamantha Cohen, Rebecca Mosig, Erin Moshier, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|December 21, 2013
The role of liver resection at the time of secondary cytoreduction in patients with recurrent ovarian cancerValentin Kolev, Elena B Pereira, Myron Schwartz, et al.
Nature Communications|January 8, 2014
microRNA-181a has a critical role in ovarian cancer progression through the regulation of the epithelial-mesenchymal transitionAditya Parikh, Christine Lee, Peronne Joseph, et al.
Pageof 3